Heterogeneity Among Ly-49C Natural Killer (NK) Cells:  Characterization of Highly Related Receptors with Differing  Functions and Expression Patterns by Brennan, Jack et al.
 
2085
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/96/12/2085/06 $2.00
Volume 184 December 1996 2085–2090
 
Heterogeneity Among Ly-49C Natural Killer (NK) Cells: 
Characterization of Highly Related Receptors with Differing 
Functions and Expression Patterns
 
By Jack Brennan,
 
*
 
‡
 
 Suzanne Lemieux,
 
§
 
 J. Douglas Freeman,
 
*
 
Dixie L. Mager,
 
*
 
‡
 
 and Fumio Takei
 
*
 
i
 
From the 
 
*
 
Terry Fox Laboratory, British Columbia Cancer Agency; the 
 
‡
 
Department of Medical 
 
Genetics, and the 
 
i
 
Department of Pathology and Laboratory Medicine, the University of British 
Columbia, Vancouver, British Columbia; and the 
 
§
 
Centre de Recherche en Immunologie, Institut 
Armand-Frappier, Université du Québec, Laval, Québec, Canada
 
Summary
 
Ly-49C is a member of the polymorphic family of murine NK cell inhibitory receptors. The
5E6 antibody that defines a subset of NK cells responsible for the rejection of parental H-2
 
d
 
bone marrow by F
 
1
 
 mice has been shown previously to react with Ly-49C. Here, the 5E6 an-
tibody was found to detect two Ly-49C-related molecules in B6 mice. Two cDNA clones
were isolated from B6 NK cells, one identical to previously reported Ly-49C
 
B6
 
 and the other a
novel cDNA. The deduced amino acid sequence of the latter differs from that of Ly-49C
 
BALB
 
at only 4 residues, whereas the previously reported Ly-49C
 
B6
 
 differs at 22 residues. Flow cyto-
metric analyses of COS cells transfected with the two cDNAs showed that the 5E6 antibody
binds to both Ly-49 molecules, while another anti-Ly-49C antibody, 4LO3311, binds to the
newly described Ly-49C but not the previously reported Ly-49C
 
B6
 
. Two-color flow cytomet-
ric analysis detected 5E6
 
1
 
4LO3311
 
2
 
 as well as 5E6
 
1
 
4LO3311
 
1
 
 subsets of NK cells from B6,
but not BALB/c, mice. The level of Ly-49C expression on B6 NK cells detected by the
4LO3311 antibody was substantially lower than that on BALB/c NK cells. Binding specificity
of the novel Ly-49C
 
B6
 
 was indistinguishable from that of Ly-49C
 
BALB
 
, whereas no binding was
detectable with previously reported Ly-49C
 
B6
 
. These results demonstrate that the newly de-
scribed Ly-49C
 
B6
 
, not the previously reported Ly-49C
 
B6
 
, is the probable B6 allelic form of Ly-
49C. The previously reported Ly-49C
 
B6
 
 must be encoded by a separate gene and should be re-
named Ly-49I. The implication of these results with respect to the role of Ly-49C in hybrid
resistance is discussed.
 
L
 
y-49C is a member of the Ly-49 family of NK cell in-
hibitory receptors (1). It was initially identified through
gene cloning based on cross-hybridization with the Ly-49A
probe (2). The 5E6 antibody, which detects NK subsets re-
sponsible for hybrid resistance against H-2
 
d
 
 but not H-2
 
b
 
bone marrow grafts in F
 
1
 
 hybrid mice (3), was subsequently
found to bind to Ly-49C (4). Flow cytometric analysis of
NK cells showed that Ly-49C is expressed on distinct NK
subsets (4, 5). In in vitro cytotoxicity assays, 5E6
 
1
 
 NK cells
from (NZB 
 
3
 
 B6)F
 
1
 
 mice lyse BALB/c (H-2
 
d
 
) but not B6
(H-2
 
b
 
) target cells (5). The resistance of H-2
 
b
 
 target cells to
5E6
 
1
 
 F
 
1
 
 NK cells is reversed by the 5E6 antibody. There-
fore, Ly-49C is considered to be an inhibitory NK receptor
for class I MHC. The specific interaction between Ly-49C
and class I MHC has been demonstrated by the binding of
cells to Ly-49C-transfected COS cells and inhibition of the
cell binding by specific class I MHC antibodies (4, 6).
Further studies to elucidate the functional role of Ly-49
in the regulation of NK cytotoxicity are complicated by
the fact that Ly-49 represents a closely related and highly
polymorphic family of molecules. It is currently difficult to
determine whether Ly-49 molecules in different strains of
mice represent allelic forms of the same loci or whether
they are encoded by different genes. Furthermore, allelic
forms of Ly-49 molecules may differ from each other in
their specificities for class I MHC. These problems are par-
ticularly relevant to hybrid resistance. The initial Ly-49C
cDNA to be described was isolated from a (B6 
 
3
 
 CBA)F
 
1
 
mouse cDNA library (2). The identical gene was found to
be expressed in BALB/c mice. A related gene, isolated
from B6 mice, differs from Ly-49C
 
BALB
 
 in 22 amino acid
residues but has been considered to be the allelic form (7).
Both Ly-49C
 
BALB
 
 and Ly-49C
 
B6
 
 are detected by the 5E6
antibody. In in vitro cytotoxicity assays, 5E6
 
1
 
 NK cells
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from B6 mice are able to kill H-2
 
d
 
, but not H-2
 
b
 
, target
cells, while those from BALB/c mice kill neither H-2
 
d
 
 nor
H-2
 
b
 
 targets (5). This difference is thought to be due to dif-
ferent ligand specificities of the two putatively allelic forms
of Ly-49C. It is unknown why 5E6
 
1
 
 NK cells of F
 
1
 
 mice
that express either or both of the two allelic forms of Ly-
49C fail to receive negative signals from parental H-2
 
d
 
bone marrow cells.
In this study, we further characterize Ly-49C from B6
and BALB/c mice by cDNA cloning as well as with a
newly available Ly-49 antibody. Our results demonstrate
that the 5E6 antibody that has been used to identify Ly-
49C in fact recognizes two distinct Ly-49C-related recep-
tors in B6 mice and that the two receptors are differentially
expressed on B6 NK cell subsets. One of the two B6 Ly-49
molecules identical to previously reported B6 Ly-49C
shows no specific binding to H-2
 
d
 
 or H-2
 
b
 
 targets, whereas
the second B6 Ly-49C molecule binds to class I MHC in a
manner indistinguishable from the BALB/c receptor. Based
upon sequence homology, the latter receptor is most likely
the B6 allele Ly-49C, whereas the former must be the
product of another gene highly related to Ly-49C. There-
fore, these findings call for a reevaluation of previous
studies that have equated 5E6
 
1
 
 NK cells with Ly-49C, par-
ticularly with regard to the role of the Ly-49C receptor in
hybrid resistance (5), as well as its potential allelic exclusion
(7, 8).
 
Materials and Methods
 
Antibodies and Flow Cytometry.
 
The 4LO3311 antibody has
been described (9). The 5E6 hybridoma was provided by Dr. V.
Kumar (University of Texas Southwestern Medical Center, Dal-
las, TX). Flow cytometric analysis of transfected COS were car-
ried out as described (4). NK cell staining procedures were as fol-
lows: splenic NK cells (3–5 
 
3
 
 10
 
5
 
) were first incubated with
unlabeled anti-FcR Ab to block nonspecific binding of anti-
Ly-49C antibodies. This Ab was purified from the supernatant of
the 2.4G2 hybridoma line purchased from the American Type
Culture Collection (Rockville, MD). NK cells were then stained
with FITC-conjugated 5E6, biotinylated 4LO3311, or both Ab
added in this sequence. SA–PE conjugate was used for the detec-
tion of the red fluorescence in one color analysis. SA–RED670
 
Ô
 
conjugate was used for two-color analysis to avoid reduction of
the green fluorescence signal by electronic compensation. Stained
cells were washed twice in PBS containing 1% BSA and 0.2% so-
dium azide. NK cell analysis based on collection of 10,000 events
per sample was performed on a Coulter Epics
 
Ò
 
XL-MLC (Coulter
Electronics, Hialeah, FL) equipped with a 488 nm argon laser.
Data analysis was done with XL software (Coulter Electronics).
 
Isolation of NK Cells.
 
IL-2-activated NK cells used for cDNA
cloning were prepared as described (4). Splenic NK cells were
isolated by nylon wool column followed by depletion of CD4
 
1
 
and CD8
 
1
 
 cells as previously described (10). Flow cytometric
analysis of the isolated NK populations showed 64–83% of these
cells from B6 mice were NK1.1
 
1
 
.
 
Ly-49C PCR. 
 
PCR primers specific for Ly-49C were de-
signed corresponding to sequences located in the 5
 
9
 
 and 3
 
9
 
 un-
translated regions of the Ly-49C
 
BALB
 
 transcript. The sequences of
the oligonucleotides were 5
 
9
 
-AGTACCGCGGAACGCCAA-
 
CGTTTCAGA-3
 
9
 
 and 5
 
9
 
-TACTCCGCGGGAGACTATGT-
TCTGTAA-3
 
9
 
. The first strand of cDNA was generated in a 25 
 
m
 
l
mixture containing 10 
 
m
 
g total RNA (isolated from B6 NK cells
cultured for 10 d in 1,000 U of IL-2), 0.5 mM each of four deox-
yribonucleotide (triphosphate), 4 
 
m
 
g/ml random hexamers, 10 mM
dithiothreitol, and 200 U of reverse transcriptase. The reaction
was incubated at 37
 
8
 
C for 1 h followed by 5 min at 95
 
8
 
C to inac-
tivate the enzyme. 1 
 
m
 
l of this reaction was then subjected to
PCR using Elongase (Canadian Life Technologies, Burlington,
Ontario) according to the protocols provided by the manufac-
turer. 35 cycles were carried out as follows: 1 min denaturation at
94
 
8
 
C; 1 min annealing at 45
 
8
 
C; and 3 min extension at 72
 
8
 
C.
This was followed by a final extension for 5 min at 72
 
8
 
C. PCR
products of 
 
z
 
1 kb in size were purified from a 0.8% agarose gel,
cut with SstII to remove the primer tails, and subcloned into the
SstII site of pBluescript-KS
 
1
 
. All PCR-derived clones described
in this paper were obtained in at least two independent PCR and
subcloning experiments and were sequenced in their entirety.
 
Transfections and Adhesion Assays.
 
The Ly-49A
 
BALB
 
 cDNA was
isolated by PCR as described by Held et al. (8). The Ly-49E
 
B6
 
and Ly-49F
 
B6
 
 cDNAs (11) were obtained from Dr. W. Yokoyama
(Washington University, St. Louis, MO), and the Ly-49G
 
BALB
 
cDNA was provided by Dr. S. Anderson (NCI, Frederick, MD).
Transfection of COS cells with Ly-49 cDNA and cell adhesion to
the transfected COS cells were carried out as described (4).
 
Results
 
Isolation of Ly-49C cDNAs from BALB/c and C57BL/6
Mice. 
 
Southern blot analysis of genomic DNA of B6
mice using a single exon probe derived from the 3
 
9
 
 end of
the Ly-49C cDNA revealed 4–5 hybridizing bands (data
not shown). Under the conditions used, the probe cross-
hybridized with Ly-49H cDNA but not other Ly-49 cDNAs
Figure 1. (A) Cytoplasmic/transmembrane domain; (B) Stalk; (C) Car-
bohydrate recognition domain (CRD). Deduced amino acid sequences of
two forms of Ly-49C from B6 NK cells. The amino acid sequences of Ly-
49CB6 and Ly-49IB6 are aligned with that of Ly-49C from BALB/c mice.
The sequences are divided into those in the cytoplasmic/transmembrane,
stalk, and CRD regions. The arrow indicates the begining of the region
within the stalk region that previously has been shown to be important
for the binding of Ly-49 to class I MHC (6). For the sequences of Ly-49C
and I from B6 mice, only the residues different from those of BALB/c
mice are shown. The CRD of Ly-49C was deduced from the previous
studies on genomic clones of Ly-49, which indicates that the CRD is en-
coded by three exons (2). The nucleotide sequence of the Ly-49CB6
cDNA is identical to an unpublished Ly-49CB6 cDNA recently deposited
in Genbank by Sentman and coworkers (these sequence data are available
from EMBL/Genbank/DDBJ under accession number U56404). 
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identified thus far (Ly-49 A, B, D, E, F, and G). Each band
likely represents an individual gene (or possibly pseudo-
genes), because sites for the restriction enzymes used for the
analysis are not found within the single exon probe. To
identify Ly-49C-related genes in B6 mice, PCR was per-
formed on cDNA prepared from IL-2-activated NK cells
from B6 mice. The PCR primers used in these experiments
were designed so as to amplify Ly-49C and none of the
other known members of the Ly-49 family. A total of eight
clones were generated and fully sequenced. One of them
was found to be identical to Ly-49C
 
B6
 
 previously reported
(7), and the other seven all encoded a novel cDNA highly
related to Ly-49C
 
BALB
 
. The predicted protein encoded by
the novel B6 cDNA differs from the Ly-49C
 
BALB
 
 by only 4
amino acids, whereas the previously reported Ly-49C
 
B6
 
differs at 22 amino acid residues (Fig. 1). At the nucleotide
level, the coding region of the novel cDNA is 99.3% identical
to that of BALB/c Ly-49C cDNA, whereas the previously
reported cDNA sequence is 95.9% identical to the BALB/c
form. For clarity, the previously reported Ly-49C
 
B6
 
 has
 
been renamed Ly-49I
 
B6
 
 and the newly described cDNA
designated Ly-49C
 
B6
 
.
 
Specificities of Anti-Ly-49C Antibodies.
 
The 4LO3311 anti-
body was previously reported to detect the NK cell antigen
NK2.1 (9, 12). The specificity of this antibody for Ly-49
was tested by the binding to COS cells transfected with in-
dividual Ly-49 cDNAs. Flow cytometric analysis of the
transfected COS cells showed that 4LO3311, like 5E6, rec-
ognizes Ly-49C
 
BALB
 
 but not Ly-49A
 
B6
 
, Ly-49A
 
BALB
 
, B
 
BALB
 
,
D
 
B6
 
, E
 
B6
 
, FB6, GB6, GBALB, or H (Gosselin, P., Y. Lusignan,
J. Brennan, F. Takei, D. Mager, and S. Lemieux, manu-
script submitted for publication). When the two B6 Ly-
49C-related molecules were tested, 4LO3311 bound only
to the novel Ly-49CB6, while 5E6 reacted with both B6
Ly-49C and Ly-49I (previously reported Ly-49CB6) (Fig. 2
A). Therefore, according to this serologic reactivity, Ly-
49CBALB and Ly-49CB6 are 5E614LO33111, and Ly-49IB6
is 5E614LO33112.
As a tool to identify the domains recognized by the
4LO3311 antibody, chimeric Ly-49CBALB/Ly-49AB6 cDNA
constructs (6) were expressed in COS cells and tested for
their antibody reactivity. 5E6 has previously been found to
bind epitopes contained within the carbohydrate recogni-
tion domain (CRD)1 (6). However, 4LO3311, was shown
to recognize an epitope located in a 32-amino acid segment
of the stalk region immediately adjacent to the CRD (Fig.
2 B). This region has previously been shown to be impor-
tant for specific binding of Ly-49C to class I MHC. In light
of the 4 amino acid differences between Ly-49CBALB and
Ly-49IB6 in this region (see Fig. 1), combined with 4LO3311
reactivity with the former but not the latter, it follows that
one or more of these four amino acid residues contribute to
the epitope recognized by 4LO3311. It is also possible that
the lack of an NH2-linked glycosylation site in this region
of Ly-49IB6 affects the binding of the 4LO3311 antibody.
Ly-49C1 NK Cell Subsets. The expression of Ly-49C
on NK cells from BALB/c and B6 mice was examined by
flow cytometry using the 5E6 and 4LO3311 antibodies.
The 4LO3311 antibody stained significant fractions of NK
cell populations from B6 as well as BALB/c mice (Fig. 3 A),
but there were significant differences between BALB/c and
B6 NK cells. The staining of BALB/c NK cells with the
4LO3311 antibody was z10-fold more intense than that of
B6 NK cells, and two times more positive cells were de-
tected in BALB/c mice.
Two-color analysis of NK-enriched spleen cells showed
that BALB/c mice possess only NK cells that are either
double-positive or double-negative for the 5E6 and 4LO3311
antibodies. In contrast, the B6 NK population consists of dou-
ble negative, double positive, and single positive (5E61
4LO33112) subsets (Fig. 3 B). Based on the specificities of
the 5E6 and 4LO3311 antibodies described above, these
flow cytometric analyses indicate that the two B6 Ly-49C-
related molecules are expressed on distinct but possibly
Figure 2. Specificities of anti-Ly-49C antibodies. (A) Ly-49CB6 and
Ly-49IB6 were expressed on COS cells and stained with 5E6 and 4LO3311.
Solid histograms represent cells transfected with Ly-49C and empty histo-
grams are cells transfected with vector alone. (B) COS cells were transfected
with chimeric Ly-49A/C as indicated and stained with A1 (anti-Ly-49A),
5E6, or 4LO3311. Solid histograms represent cells transfected with chi-
meric Ly-49 and empty histograms are cells transfected with vector alone.
1Abbreviation used in this paper: CRD, carbohydrate recognition domain.2088 Heterogeneity Among Ly-49C NK Cells
overlapping subsets of NK cells, while no such heterogene-
ity is observed with BALB/c NK cells. It should be noted
that the double-positive subset of B6 NK cells seems to
contain at least two populations differing in the intensities
of 5E6, but not 4LO3311, staining. They may represent
cells expressing Ly-49C alone and those coexpressing Ly-
49C and Ly-49I. It is also possible that these two antibodies
may detect other Ly-49 molecules yet to be described on
the double positive population.
Recognition of Class I MHC by B6 and BALB/c Ly-49C
Receptors. 5E61 NK cells have been thought to receive
negative signals upon interactions of Ly-49C with H-2b
and, under certain circumstances, H-2d antigens on target
cells. After having shown that 5E61 NK cells in B6 mice
actually comprise two distinct NK cell subsets and that each
of these express distinct but highly related receptors, we
next investigated the class I MHC binding properties of
each of these B6 receptors. It has been shown previously
that Ly-49AB6 and Ly-49CBALB expressed on COS cells by
cDNA transfection mediate cell–cell adhesion by binding
to class I MHC antigens on various opposing cell lines (6).
Ly-49AB6 has been shown to bind H-2d structures (but not
H-2b), whereas Ly-49CBALB binds to both H-2d and H-2b.
When this same assay was used to test the B6 Ly-49 recep-
tors, Ly-49CB6 bound to both H-2d and H-2b, as was the
case for the highly related Ly-49CBALB (Fig. 4 A). Interest-
ingly, Ly-49IB6 did not show any class I binding ability in
this assay system. The binding was almost completely in-
hibited by the 4LO3311 antibody (Fig. 4 B), further indi-
cating that the cell adhesion in this system is mediated by
Ly-49C.
Discussion
The results presented in this report have demonstrated
that two Ly-49C-related molecules are expressed on NK
cells from B6 mice. Although Ly-49C1 NK cells in B6 mice
were previously identified by the 5E6 antibody, our cur-
rent data have shown that this NK subset is, in fact, hetero-
geneous and can be divided into subpopulations based on
the expression of the two Ly-49 molecules. One of the two
Ly-49 molecules described in this study, Ly-49IB6, is iden-
tical to the previously reported Ly-49CB6 that was consid-
ered to be allelic to Ly-49CBALB (7). However, the deduced
amino acid sequence of the other Ly-49 is much closer to
Figure 3. Expression of Ly-49C on NK cells from BALB/c and B6 mice. (A) Splenic NK cells were first incubated with unlabeled anti-FcR (2.4G2)
to block nonspecific binding of antibodies then stained with FITC-conjugated 5E6 or biotin-conjugated 4LO3311 and SA–PE. The x and y axes corre-
spond to the log fluorescence intensity and cell count, respectively. Solid histogram shows anti-Ly-49C staining and dotted histogram shows autofluo-
rescence of unstained cells. No difference was observed between unlabeled cells and cells incubated with FITC- or biotin-conjugated isotype-control
mAbs (data not shown). (B) NK cells were stained for two-color analysis as described for A, except that SA–RED670TM conjugate was used for the de-
tection of the red fluorescence. The electronic compensations for the two-color analysis were set on samples incubated with each antibody alone.2089 Brennan et al.
the Ly-49CBALB sequence than that of Ly-49I (4 residue
difference versus 22 residue difference). More importantly,
this newly described Ly-49CB6 shows the same binding
specificity for class I MHC as that of Ly-49CBALB, whereas
no binding of Ly-49I to those class I MHC is detectable in
the cell binding assays in this study. Therefore, the newly
described Ly-49CB6 is more likely the B6 allelic form of
Ly-49C. The previously reported Ly-49CB6 must be en-
coded by a different but highly related gene and has been
renamed Ly-49IB6.
Based on our finding that the 5E6 antibody binds to two
different Ly-49 receptors, Ly-49CB6 and Ly-49IB6, on B6
NK cells and that these receptors differ in terms of their
class I recognition abilities and expression on NK cell sub-
sets, our previous understanding of 5E61 NK cells is con-
sidered both simplistic and inaccurate. The 5E6 antigen
was originally defined as a marker of an NK cell subset in
F1 hybrid mice that rejects parental H-2d but not H-2b
bone marrow grafts (3). The subsequent identification of
5E6 as Ly-49C and the modulation of NK cell killing in
vitro with anti-5E6-Ab has served as strong support that
this molecule functions as an inhibitory receptor for class I
MHC (5). The role of Ly-49C in hybrid resistance has
been complicated by the finding that 5E61 NK subsets
from B6 and BALB/c mice differ from each other in their
target specificities. The former kill H-2d, but not H-2b, tar-
gets, whereas the latter do not effectively kill either target
(5). To reconcile these in vitro results with the in vivo ob-
servation of hybrid resistance, it was proposed that the two
allelic forms of Ly-49C, having significantly different
amino acid sequences, may differ in their specificities for
class I MHC and that Ly-49CB6 may be preferentially ex-
pressed on F1 NK cells, possibly by allelic exclusion (5, 8).
However, our present results indicate that Ly-49CBALB and
the likely B6 allelic form, Ly-49CB6, have the same binding
specificities, whereas Ly-49IB6 does not bind to H-2d or
H-2b target cells. Why, then, do NK cells from F1 mice fail
to receive inhibitory signals from H-2d target cells? Perhaps,
this question can be answered by the receptor calibration
model (13–15). According to this model, the expression
levels of individual Ly-49 molecules are downregulated by
self-class I MHC that interact with Ly-49. Furthermore,
inhibition of NK cytotoxicity by Ly-49 is dependent on its
level of expression, which is controlled by the affinity of
interaction between Ly-49 and particular self-MHC. We
have demonstrated that the level of Ly-49C on BALB/c
NK cells is nearly 10-fold higher than the level of Ly-
49CB6 on B6 NK cells as determined by the staining with
the 4LO3311 antibody (Fig. 3 A). Based on the receptor
calibration model, it is likely that the affinity of the interac-
tion between Ly-49C and H-2d is lower than that between
Ly-49C and H-2b. Thus, Ly-49C1 BALB/c NK cells can
be inhibited by H-2d despite the low affinity interaction
due to the high level of Ly-49C expression. In contrast,
Ly-49C1 NK cells from B6 mice, and likely from F1 mice
as well, fail to receive inhibitory signals from H-2d because
of the low Ly-49C expression and the low affinity interac-
tion, but are inhibited by H-2b due to its relatively high af-
Figure 4. Binding of Ly-49C to target cells. (A) COS cells were transfected with
vector alone (a, b), Ly-49CBALB (c, d), Ly-49CB6 (e, f ), or Ly-49IB6 (g, h), and incu-
bated with the murine lymphoid lines A20 (H-2d) (a, c, e, g) and IC-21 (H-2b) (b, d,
f, h). After a 2 h coincubation, unbound cells were washed away, and plates were
photographed. (B) The binding of IC-21 cells to COS cells transfected with Ly-
49CB6 was tested as above in the absence (a) or presence (b) of the 4LO3311 anti-
body. IC-21 binding to cells transfected with vector alone is shown in the absence (c)
or presence (d) of 4LO3311.2090 Heterogeneity Among Ly-49C NK Cells
finity interaction. Recent findings that the expression level
of Ly-49C is indeed regulated by class I MHC of the host
(Gosselin, P., Y. Lusignan, J. Brennan, F. Takei, D. Mager,
and S. Lemieux, manuscript submitted for publication) fur-
ther supports this model.
It is of interest that the 4LO3311 antibody binds to the
stalk region of Ly-49C and yet it effectively inhibits the
binding of target cells to Ly-49C-transfected COS cells. On
the other hand, 5E6 binds to the CRD and also inhibits the
binding of class I MHC to Ly-49C. Previous studies of
Ly-49C have found sequences in both the CRD and in
the stalk region immediately adjacent to the CRD to be
important in binding to class I MHC (6). The results with
4LO3311 further support the hypothesis that the recogni-
tion of class I MHC involves both the CRD and the stalk
region of Ly-49C.
These results have demonstrated the complexity of the
NK cell receptor Ly-49. The unexpected cross-reactivity
of the 5E6 antibody exemplifies the potential problem as-
sociated with a highly polymorphic and complex family of
molecules such as Ly-49. Until all the Ly-49 genes and the
proteins are identified, precise specificities of existing Ly-49
antibodies require careful examination. At the same time,
our results suggest a relatively simple explanation of the
question of how hybrid resistance is regulated by Ly-49.
The finding that the previously reported Ly-49CB6 is un-
likely to be the B6 allelic form of Ly-49C also calls for a re-
evaluation of allelic exclusion of Ly-49C (8).
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